Learn more about whether Halozyme Therapeutics, Inc. or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Data shared in collaboration with The University of Texas Medical Branch, representing an analysis of more than one million intravenous (IV) infusions using Baxter’s Spectrum IQ large volume infusion ...

Sweat is turning into one of medicine’s most revealing data streams, and artificial intelligence is learning how to read it. Instead of relying only on blood draws or implanted devices, researchers ...

Extracorporeal membrane oxygenation (ECMO) technology has relative contraindications in haemorrhagic disease but remains an effective therapeutic option for the treatment of pulmonary haemorrhage ...

The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and ...

Intravenous (IV) and subcutaneous (SC) formulations each play important roles in modern oncology care, with distinct ...

The FDA has approved the subcutaneous administration of a fixed combination of amivantamab (Rybrevant; Johnson & Johnson) and a recombinant human hyaluronidase for patients with non–small cell lung ...

New genetic research shows that DNA and archaeological evidence align with the "long chronology" of the peopling of Australia. When you purchase through links on our site, we may earn an affiliate ...

Maybe that’s why cats don’t have fingerprints like yours. I asked my friend Katherine Corn about that. She’s an evolutionary functional morphologist. She studies how animal bodies evolved to do all ...

Indivior PLC today announced results from a randomized, double-blind clinical trial published in JAMA Network Open. The study found that both the 100-mg and 300-mg monthly maintenance doses ...

This guidance should be used alongside the following resources: Measles is highly infectious and has multiple differential ...